Edition:
United Kingdom

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

18.28HKD
21 May 2018
Change (% chg)

HK$-0.76 (-3.99%)
Prev Close
HK$19.04
Open
HK$19.10
Day's High
HK$19.48
Day's Low
HK$18.26
Volume
41,025,370
Avg. Vol
27,626,023
52-wk High
HK$19.66
52-wk Low
HK$6.49

Chart for

About

Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of modernized Chinese medicine products... (more)

Overall

Beta: 0.54
Market Cap(Mil.): HK$160,415.70
Shares Outstanding(Mil.): 8,425.19
Dividend: 0.02
Yield (%): 0.39

Financials

  1177.HK Industry Sector
P/E (TTM): 52.71 28.57 32.53
EPS (TTM): 0.36 -- --
ROI: 33.52 13.08 12.63
ROE: 25.37 14.80 14.50

BRIEF-Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing​ & Super Demand

* CO TO ACQUIRE SINO BIOPHARM BEIJING​,WHICH OWNS 33.6% OF BEIJING TIDE, BY ISSUING 723.3 MILLION SHARES AT HK$12.73 PER ISSUE SHARE

05 Jan 2018

BRIEF-Sino Biopharmaceutical Product Granted Drug Registration Approval By State FDA Of China​

* "TENOFOVIR DISOPROXIL FUMARATE TABLET" GRANTED DRUG REGISTRATION APPROVAL BY STATE FOOD AND DRUG ADMINISTRATION OF CHINA​

05 Dec 2017

Earnings vs. Estimates